Remove 2020 Remove Pharmaceutical manufacturing Remove Safety
article thumbnail

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. For manufacturers, this allows for greater protection of products courtesy of real-time tracking data and the ability to refine and secure supply chains by spotting weak links.

article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. Regulatory Compliance Regulatory frameworks are continuously evolving in the pharmaceutical industry.

Pharma 91
article thumbnail

Cleanroom microbiology: single-temperature incubation for EM

European Pharmaceutical Review

To say that 25°C is the only valid temperature is erroneous, but in view of the data generated in our context, it remains the optimum temperature for the detection of contamination in our production environment, thus guaranteeing drug quality and, ultimately, patient safety. Automation has proved its worth in terms of early colony detection.

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

According to an August 2021 report from the Business Research Company , after experiencing a decline in 2020 due to pandemic, the medication adherence market is expected to recover and grow at a compound annual growth rate (CAGR) of 11.4% KEEP was named in the top 100 best inventions list in TIME magazine following its launch in 2020.

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions. pdf; 21 C.F.R. 562, 117th Cong. §

article thumbnail

Everything You Need to Know About Market Access in China

PM360

During the application stage, manufacturers should formulate principles and prepare a value dossier which is structuralized in a similar way as a classic payer value story. The content of the value dossier should consist of product introduction, effectiveness, novelty, safety, economic value, and equity. Kapusniak, C. Rémuzat, Y.

Marketing 105
article thumbnail

Top 5 Emerging Trends in Pharma Industry

Medico Reach

The global pharmaceutical manufacturing market stood at USD 405.52 billion in 2020 and will project growth of USD 4.18 billion during 2020-2024. The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. from 2023 to 2030.

Pharma 52